Molecular Biology of Neuropsychiatric Disorders

It is generally accepted that neuropsychiatric disorders have a biological basis. Pathological changes leading to illness have been confirmed for Alzheimer’s (amyloid plaques) and Parkinson’s disease (loss of dopaminergic transmission) and are the foundation for studies on the molecular biology of t...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Wildenauer, Dieter B. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg, 2009.
Σειρά:Nucleic Acids and Molecular Biology, 23
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03367nam a22005415i 4500
001 978-3-540-85383-1
003 DE-He213
005 20151030111451.0
007 cr nn 008mamaa
008 100301s2009 gw | s |||| 0|eng d
020 |a 9783540853831  |9 978-3-540-85383-1 
024 7 |a 10.1007/978-3-540-85383-1  |2 doi 
040 |d GrThAP 
050 4 |a QP351-495 
072 7 |a PSAN  |2 bicssc 
072 7 |a SCI070000  |2 bisacsh 
072 7 |a MED057000  |2 bisacsh 
082 0 4 |a 573.8  |2 23 
245 1 0 |a Molecular Biology of Neuropsychiatric Disorders  |h [electronic resource] /  |c edited by Dieter B. Wildenauer. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg,  |c 2009. 
300 |a XIII, 294 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Nucleic Acids and Molecular Biology,  |x 0933-1891 ;  |v 23 
505 0 |a Decoding the Genetics and Underlying Mechanisms of Mood Disorders Sevilla D. Detera-Wadleigh and Takeo Yoshikawa -- Dissecting the Molecular Causes of Schizophrenia -- Autism Spectrum Disorders -- Molecular Genetics of ADHD -- The Genetics of Anxiety Disorders -- Molecular Biology of Addiction and Substance Dependence -- Neurobiology of Suicide -- Molecular Genetics of Alzheimer's Disease -- Molecular Biology of Parkinson's Disease. 
520 |a It is generally accepted that neuropsychiatric disorders have a biological basis. Pathological changes leading to illness have been confirmed for Alzheimer’s (amyloid plaques) and Parkinson’s disease (loss of dopaminergic transmission) and are the foundation for studies on the molecular biology of these disorders. For other neuropsychiatric disorders, in particular for schizophrenic and affective disorders, molecular causes appear to be more complex and therefore remain hypothetical, despite decades of research. Changes in a number of neuronal pathways and structures have been reported to be associated with these disorders and are currently under extensive investigation. The present volume reviews recent knowledge with emphasis on ongoing research findings. Current hypotheses based on these findings are described and discussed. Knowing the molecular basis of these disorders is not only of academic interest, but is essential for: • identifying risk factors contributing to the development of the disorders, • detecting biomarkers which will aid in diagnosis, • providing new and specific targets for development of causal pharmacological treatment. 
650 0 |a Life sciences. 
650 0 |a Molecular biology. 
650 0 |a Neurology. 
650 0 |a Biochemistry. 
650 0 |a Neurobiology. 
650 0 |a Neuropsychology. 
650 1 4 |a Life Sciences. 
650 2 4 |a Neurobiology. 
650 2 4 |a Neuropsychology. 
650 2 4 |a Molecular Medicine. 
650 2 4 |a Neurology. 
650 2 4 |a Biochemistry, general. 
700 1 |a Wildenauer, Dieter B.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783540853824 
830 0 |a Nucleic Acids and Molecular Biology,  |x 0933-1891 ;  |v 23 
856 4 0 |u http://dx.doi.org/10.1007/978-3-540-85383-1  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)